Investing.com - Select Medical (NYSE: SEM) reported third quarter EPS of $0.46, $0.05 better than the analyst estimate of $0.41. Revenue for the quarter came in at $1.67B versus the consensus estimate of $1.63B.
Guidance
Select Medical sees FY 2023 EPS of $1.85-$2.02 versus the analyst consensus of $1.98.
Select Medical sees FY 2023 revenue of $6.55B-$6.70B versus the analyst consensus of $6.62B.
Select Medical's stock price closed at $23.00. It is down -23.21% in the last 3 months and down -3.12% in the last 12 months.
Select Medical saw 0 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Select Medical's stock price’s past reactions to earnings here.
According to InvestingPro, Select Medical's Financial Health score is "good performance".
Check out Select Medical's recent earnings performance, and Select Medical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar